Print

Vivant Medical Announces Abstracts Accepted At National Meetings In 2005 That Highlight Data From Studies Using Microwave Ablation In Lung, Kidney And Liver 
10/19/2005 5:13:00 PM

MOUNTAIN VIEW, Calif., March 14 /PRNewswire/ -- Vivant Medical, Inc. announced today that five scientific abstracts from prospective clinical studies using the VivaWave(TM) Microwave Ablation System have been accepted for presentation in 2005 and will be presented by their respective clinical investigators. These abstracts, which build upon 2004 presentations, provide results in lung, kidney and liver ablations.

Two abstracts will be presented at the Society of Interventional Radiology, March 31-April 5 in New Orleans; and one abstract will be presented at the American Hepato-Pancreato-Biliary Association, April 14-17 in Fort Lauderdale; and the American Urological Society, May 21-26 in San Antonio. An abstract was already presented at the Society of Gastro Intestinal Radiology earlier this month in San Antonio.

Image-guided ablative therapies have received significant attention in recent years as a minimally invasive approach for treating localized diseased tissue, particularly for patients who are poor surgical candidates. Microwave ablation offers cost benefits versus other ablative technologies because of broader patient selection criteria and decreased procedure time.

Vivant's VivaWave system is a proprietary ablation system that utilizes microwave heating to kill target cells. VivaWave has been used in over 275 procedures performed by interventional radiologists and surgeons. Results show that microwave ablation creates large ablation zones (5-6 cm) quickly (5- 10 minutes) through the use of multiple concurrent applicators, allowing more patients to be treated cost effectively. In addition, no grounding pads are needed and anesthesia time is reduced.

Rod Young, president of Vivant Medical, commented, "I am confident that ongoing clinical studies using VivaWave will continue to validate the utility of microwave ablation in a broad range of clinical applications. We are pleased to offer physicians, as well as patients, the possibility of even greater options through the VivaRing and VivaTip applicators."

About Vivant Medical, Inc.

The VivaWave Microwave Ablation System is a novel and proprietary technology developed by Vivant Medical, Inc., Mountain View, California, USA. The VivaWave System has received FDA 510(k) clearance for the coagulation of soft tissue, and the system is in clinical usage at medical centers and university hospitals worldwide.

Vivant Medical Alice Jack Vice President, Marketing and Sales 650-694-2900 ajack@vivantmedical.com The Ruth Group Janine McCargo Account Supervisor 646-536-7033 jmccargo@theruthgroup.com

Vivant Medical, Inc.

CONTACT: Alice Jack, Vice President, Marketing and Sales, VivantMedical, Inc., +1-650-694-2900, ajack@vivantmedical.com; Janine McCargo,Account Supervisor, The Ruth Group, +1-646-536-7033,jmccargo@theruthgroup.com, for Vivant Medical, Inc.


//-->